Clinical Trial

Care Coordination to Assess Improvement in Outcomes in Hospital Readmissions

Study acronym: COMPASSION
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 20, 2024 (before its estimated February 22, 2025 completion). Its status may not reflect the trial's current state.
Summary
Heart failure is a syndrome that is defined by distinctive clinical, hemodynamic, and neurohormonal findings. HF represents a final common pathway for many different cardiovascular diseases, including coronary disease, hypertension, Valvular disease, and many primary heart muscle diseases. Clinically, HF patients experience dyspnea, fatigue and diminished exercise tolerance, reflecting elevated left and/or right ventricular filling pressures and decreased cardiac output.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2021-05-24; most recent amendment 2024-03-19.
Trial Details
NCT Number NCT04905160
Lead Sponsor Aventyn, Inc.
Collaborators: TwinEpidemic, Arizona State University, Intel Corporation, Heart Health Organization East Valley
Conditions Heart Failure, ADHF, Acute MI
Enrollment 1,000 participants
Start Date 2021-02-18
Primary Completion 2025-02-22 (estimated)
Study Completion 2026-12-22 (estimated)
Updated on ClinicalTrials.gov 2024-03-20